Early movers: LLY, DE, HPE, HPQ, URBN, GME, MSG, FB & more
Eli Lilly — The drugmaker said its experimental Alzheimer's drug failed to meet its goals in a phase 3 study, ...
Eli Lilly — The drugmaker said its experimental Alzheimer's drug failed to meet its goals in a phase 3 study, ...